Abstract
990TiP - Phase III LEAP-011 trial: First-line pembrolizumab with lenvatinib in patients with advanced urothelial carcinoma ineligible to receive platinum-based chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have